Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ATG-012 + ET0038 |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ATG-012 | ATG 012|ATG012 | KRAS G12C inhibitor 34 | ATG-012 inhibits KRAS G12C, potentially resulting in inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2679). | |
ET0038 | ET 0038|ET-0038 | SHP2 Inhibitor 20 | ET0038 inhibits SHP2, potentially resulting in inhibition of tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr 2679). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|